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CHAPTER I 
 
 
INTRODUCTION 
 
1.1 Motivation for Regenerative Techniques for Cartilage 
There are approximately 600,000 knee replacement surgeries every year in the United 
States.  Some causes for the surgery can be due to but not limited to osteoarthritis or 
direct injury from athletics.  Additionally, osteoarthritis commonly affects the older age 
groups whereas the sports related injuries are typically found in the age group of adults to 
young adults (Banzon 2009).  Furthermore, osteoarthritis has been found to affect athletes 
that have suffered a direct cartilage injury that has not been repaired.  In 2005, an 
estimated twenty seven million adults were diagnosed with OA (Center for Disease 
Control and Prevention 2010).  Furthermore, over a ten year period, there was a 
documented 7,769 sports related knee injuries reported from 6,434 patients; and of those, 
cartilage lesions consumed 10.63% of the knee injuries (Majewski et al. 2006).  Medical 
options for people suffering from knee injuries include total knee replacement, 
reconstructive surgery, and rehabilitation that can cause the patients to be in bed rest 
anywhere from days to weeks depending on the severity of the injury.  However, some 
people suffering from OA or athletic injuries may be unable to have surgery due to the 
lack of insurance or funds.  Knee surgeries can be cost effective depending on a person’s
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insurance situation and the extensiveness of the surgery.  The total cost of medical care 
for OA was $37.5 Billion in 2009 (Hospital and Health Networks 2011).  There are many 
variables affecting the cost of surgery, some include surgeon, pharmaceutical and facility 
fees, as well as the cost to obtain and isolate cartilage cells, or chondrocytes.  Because 
chondrocytes have low regenerative capabilities and offer no possibility for natural 
healing, a replacement strategy has been explored in the form of stem cell differentiation.  
This technique focuses only on the biological side of cartilage replacement and is limited 
under clinical conditions.  An artificial tissue, serving as a platform, must be both 
biocompatible and biodegradable for the chondrocytes to proliferate and reconstruct the 
natural cartilage.  
Allografts and biodegradable polymer based structures have been explored as surgical 
alternatives for cartilage.  Extensive studies have been performed to develop a suitable 
alternative tissue for cartilage as well as deriving chondrocytes from another cell line.  
The materials used for the tissue development and fabrication are natural and synthetic 
polymers.  These materials are utilized for grafting and injection in physical forms such 
as porous scaffolds and injectable hydrogels.  Since hydrogels, which are cross-linked 
hydrophilic polymers, contain large amounts of water similar to cartilage; this makes 
them attractive in cartilage regeneration.  In particular, injectable hydrogels are 
minimally invasive for arthroscopic surgeries and easy to incorporate cells and bioactive 
agents.  An attractive method is using chitosan as the base material to prepare the 
hydrogels at body temperature using β-glycerophosphate (GP) chemistry.  The solution 
remains in liquid phase at room temperature and gels irreversibly upon increasing body 
temperature.  However, a major weakness of hydrogels is mechanical strength; strategies 
3 
 
to improve the compressive property to comparable levels of cartilage, which range from 
35 to 2000 kPa, must be explored (Werkmeister et al. 2010).  A weakness of chitosan is 
its lack of a cell binding domain thus, requiring the addition of polymers that contain this 
property.  The cell binding domain influences cell-cell and cell-matrix interactions in 
three-dimensional (3D) systems, which are crucial to integrate the extensive signaling 
pathways, the biophysics, and the biomechanics that regulate the development, 
homeostasis, and regeneration of tissues.   
Allogeneic stem cells capable of differentiating into chondrocytes have been explored in 
cooperation with 3D matrices.  Some efforts have focused on comparing the phenotypic 
differences between fibroblasts with adult human mesenchymal stem cells (hMSCs) 
(Blasi et al. 2011).  However, there has been no comprehensive study that involves a 
biopolymer structure that can be used as a minimally invasive alternative for cartilage 
repair with the inclusion of an autologous cell source that has potentiality to differentiate 
in to the chondral cell line.  Human foreskin fibroblasts (hFF-1) are targeted because they 
are easily obtained from a small biopsy of autologous skin, able to be programmed into 
induced pluripotent stem (iPS) cells, and easily populated in tissue culture in serum free 
medium which minimizes safety concerns related to xenogeneic products. 
 
1.2 Objectives and Hypothesis 
The objectives of this study were to investigate a hydrogel system that is easy to utilize in 
clinical settings to produce cartilage and an autologous cell source such as easily 
available hFF-1.  3D systems based on mimicking in vivo environments provide a 
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substantial new integrative level of complexity to the cells.  An injectable solution system 
based on the extracellular matrix (ECM) elements present in cartilage was utilized to 
fabricate gels with properties similar to cartilage at body temperature.  Chitosan, which is 
biodegradable and biocompatible, was chosen as the base polymer for construction of the 
hydrogel.  Chitosan has a net positive charge for immobilizing negatively charged 
molecules such as glycosaminoglycans and gelatin but contains no cell binding domain. 
Therefore, gelatin was used for the purposes of cell binding due to its Arg-Gly-Asp 
(RGD)-like sequence that promotes cell adhesion and migration (Huang, Onyeri et al. 
2005).  Additionally, gelatin can be combined with chitosan in the absence of a cross-
linker (Mao 2003).   
1. The first objective was to evaluate a hydrogel system that is easy to utilize in clinical 
settings to produce cartilage.  In order to use a hydrogel for cartilage in a clinical 
setting, we must meet the mechanical characteristics of cartilage.  We hypothesized 
that increasing the concentration of chitosan would increase the mechanical 
properties.  To test the hypotheses, we prepared chitosan-gelatin at concentrations of 
2%/0%, 2%/1%, and 2%/2%.  First, we analyzed the rheological properties of the 
hydrogel at a 2%/2% chitosan-gelatin supplemented with glycerol 2-phosphate 
concentration.  Next, we measured the compressive properties of the hydrogels at 
37oC using a custom-built two anvil apparatus.  These results showed suitable 
mechanical properties of the hydrogels for cartilage applications.  
2.  The second objective was to investigate an autologous cell source such as hFF-1 for 
chondrocytes and measure viability in a regenerative tissue.  For the purposes of a 
clinical setting, autologous cell source with minimally invasive harvesting protocol 
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would significantly enhance the applicability of regenerating cartilage.  Hence, 
human foreskin fibroblasts were cultured in both pellet and hydrogel systems similar 
to hMSCs and supplemented with a transforming growth factor (TGF-β3) for 
differentiation.  Quantification of differentiation was measured with a Collage Type II 
ELISA, the expression hyaluronan (CD44) and laminin-binding surface receptors 
(CD151) via flow cytometry, histology analysis, and the expression of degradation 
enzymes MMP-2/MM-9 and MMP-13.  Additionally, the capabilities of 
differentiation for an autologous cell source would be similar to that of a stem cell 
source in both pellet and hydrogel systems.  The viability and proliferation of a 
differentiated autologous cell source was possible in the more concentrated chitosan-
gelatin injectable hydrogels. 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
2.1 Cartilage Regeneration Techniques 
Articular cartilage covers the ends of all bones that form articulating joints in humans and 
animals.  The cartilage acts in the joint as a mechanism for force distribution and as a 
lubricant in the area of contact between the bones.  Without articular cartilage, stress 
concentration and friction would occur to the degree that the joint would not permit ease 
of motion.  In general, articular cartilage consists of cells called chondrocytes with cell 
volume averaging only 2 to 3% of the total.  Nearly 15% is occupied by an extensive 
extracellular matrix (ECM) consisting of collagen type II, glycosaminoglycans, 
proteoglycans, and elastins (Fox et al. 2009).  When a person injures cartilage, either by 
physical activity or deterioration over time, the cartilage is unable to heal spontaneously.  
This is primarily because articular cartilage has poor regenerative and reparative abilities 
following injury or degenerative diseases (Toh et al. 2010).  Damaged articular cartilage 
can severely restrict joint function, causing debilitating pain.  Thus, small lesions usually 
result in progressive deterioration and eventual joint diseases including osteoarthritis 
(OA), requiring joint reconstruction/repair (Hospital and Health Networks 2011). 
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An alternative strategy mimicking natural cartilage is the key to successfully reducing the 
cost and care of cartilage issues (Gong et al. 2010, Bobick et al. 2009, Diekman et al. 
2010, Tew et al. 2008).  Current conventional treatment modalities for damaged meniscal 
cartilage include the removal and/or surgical repair of the damaged cartilage.  
Osteochondral allografting and autografting are currently the only options that have 
demonstrated some potential to restore mature hyaline cartilage.  Allografts are 
transplantable tissues from another person with a different genotype.  Autografts are 
tissues from the patient’s body that can be used for transplantation at a different place in 
their body.  Despite developments in surgical procedures, the cartilage tissue replacement 
with structures consisting of permanent artificial materials has been less than satisfactory, 
due to many factors such as need for immunosuppressive therapy, and mechanical 
mismatch of the donor cartilage.  In some cases, there is also an increased risk of 
degenerative arthritis.  Recently, tissue engineering approaches have offered new 
possibilities for the restoration of damaged or lost tissue.  Chondrocytes transplantation 
has been reported in many preclinical and clinical studies. 
 
2.2 Scaffold based Tissue Engineering  
Tissue engineering applies the principles of biology and engineering to the development 
of functional substitutes for damaged tissues (Langer et al. 1993).  The concept of tissue 
engineering is that cells isolated from a patient or donor, propagated in vitro in a suitable 
environment with proper growing conditions, seeded onto a biocompatible and 
biodegradable platform and once confluent grafted into the patient as a replacement for 
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Figure 2.1.  Flow chart for traditional tissue engineering techniques used currently.  Source: Hyalograft® C Autograft: 
Anika Therapeutics 2011, Patient: Christopher Ligori and Associates 2011. 
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the damaged tissue.  Figure 2.1 illustrates the steps involved in scaffold based tissue 
engineering process.  The replacement scaffold must be biocompatible, which involves 
the use of materials that promote functional characteristics and cell attachment but do not 
provoke unwanted tissue responses, and biodegradable, which implies the ability of the 
material to degrade into non-toxic materials leaving only living tissue.  These 
characteristics are possessed by materials such as ceramics, metals, natural and synthetic 
polymers and a combination thereof (Yang et al. 2001).  Many in vitro experiments show 
that cells respond differently in attachment, morphology, migration, and proliferation on 
three-dimensional scaffolds (Lawrence et al. 2008).  Scaffolds provide physical cues to 
guide cell colonization as well as chemical cues of cell-binding sites to support cell 
attachment and spreading.  Cellular growth and function is influenced by scaffold 
stiffness of the substrate challenge of tissue engineering cartilage is to provide the 
essential cells and signals that will establish a cartilage extracellular matrix and 
recapitulate this molecular organization that forms the basis for the essential mechanical 
properties of the tissue.  Although the polymer based scaffolds have shown promise to 
regenerate cartilage (Ragetly et al. 2010), implantations of these structures require 
invasive surgical procedures. Polymer based hydrogels have been explored more recently 
for use as regenerative cartilage.   
 
2.3 Cartilage Extracellular Matrix and Components 
Before exploring the material selection in more depth, a better understanding must be 
established for the extracellular matrix (ECM) components of cartilage itself.  This is to 
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determine which materials are important for developing a regenerative tissue that would 
most closely resemble natural cartilage.  Further, the function of articular cartilage as a 
load-bearing tough elastic tissue is based on the unique structure of chondrocytes 
dispersed in an organized gel-like ECM.  The ECM can be considered as the foundation 
that controls the tissue structure by holding the cells together and regulating the cell 
phenotype (Stevens et al. 2005).  The ECM for cartilage represents the microenvironment 
for chondrocytes and depends on the interaction with their pericellular matrix to maintain 
a stable cellular phenotype (Gentili et al. 2009).  These components are produced by the 
resident chondrocytes and can take up a variety of forms in different tissues.  
Additionally, the ECM stores variety of soluble factor such as cytokines and growth 
factors and modulates their activation status and turnover (Kresse et al. 2001).  The ECM 
of tissues consists mainly of proteins, glycoaminoglycans (GAGs), glycoproteins and 
small molecules arranged in a structural support matrix.  The ECM components that are 
specific to cartilage are Collagen Type II, Aggrecan, Hyaluronan, tropoelastins and 
matrix metalloproteinases (MMPs).  More specifically, Collagen Type II makes up 
approximately 60% dry weight of articular cartilage while the rest of the ECM is 
comprised of 25-35% dry weight PG and 15-20% dry weight other non-collagenous 
proteins (Mow et al. 1999). 
Collagens are connector fibril proteins and are the principle constituents of cartilage.  
Together with proteoglycans (PGs) and GAGs filling the extracellular space, collagen 
type II fibers provide tensile strength and create space for the tissue while allowing 
diffusion of nutrients, metabolites and growth factors (Kim et al. 1998).  The 
proteoglycans provide the compressive stiffness necessary for normal articulation and 
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function.   Additionally, collagen has been used for drug delivery systems because of its 
ability to facilitate wound repair (Friess 1998).  Hyaline cartilage contains high levels of 
a cartilage specific proteoglycan, Aggrecan (Roughley et al 1994).  As a result of the 
aforementioned studies, Collagen Type II production was chosen to be the main 
component to be observed in this study.   
Proteoglycans (PGs) are macromolecules of covalently bonded carbohydrate chains 
GAGs (particularly chondroitin sulfate in cartilage) attached to a core protein and are 
present in many different forms in ECMs of connective tissues (Iozzo et al 1996).  The 
role PGs in the ECM is to serve as tissue organizers, influence cell growth and maturation 
of specialized tissue, play a role as biological filters and modulate growth-factor 
activities, regulate collagen fibrollogenesis and skin tensile strength, affect tumor cell 
growth and invasion, and influence corneal transparency and neurite out-growth (Iozzo et 
al. 1998).  Aggrecan is the most commonly found PG in hyaline and articular cartilage 
and is able to interact with hyaluronan to form large PG aggregates (Gentili et al. 2009).  
Hyaluronan or hyaluronic acid (HA) is a large negatively charged polysaccharide and 
serves as a lubricant in tissue joints.  In adult cartilage, HA binds to aggrecan to maintain 
high concentrations of aggrecan for tissue compressive resilience (Gentili et al. 2009).  
The aggregate structure formed represents a major attractor for water molecule that 
hydrates the cartilage matrix (Jarvelainen et al 1991).   
The remainder of components contributes a small portion of the overall composition of 
the extracellular matrix.  The smaller molecules of the ECM consist of tropoelastins, and 
matrix metalloproteinases (MMPs).  Tropoelastins are the base forms for elastins which 
work as rubber bands for assisting the tissue in returning to its natural state (Iyer et al 
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2011).  MMPs are enzymes that are mainly responsible for the degradation of ECM 
elements.  Loss of GAGs in arthritic patients has been attributed to the increased 
production of MMP-3 or stromelysin (Fosang et al., 1996).  MMP-2 (Gelatinase A), a 
constitutively produced homeostatic enzyme, degrades gelatin (Makowski et al., 1998).  
Further, MMP-9 (gelatinase B), which is expressed in acute and chronic inflammations, 
also degrades gelatin.  Degradation of collagen type II involves MMP1, MMP8 and 
MMP13.  Furthermore, MMP-13 has been demonstrated to cleave collagen type II, which 
is predominant in cartilage, more readily than types I and III (Knauper V et al. 1996).  
MMP-13 cleaves fibrillar collagens with preference to type II collagen over type I and III 
collagens, and displays over 40-fold stronger gelatinase activity than MMP-1 and MMP-
8.  MMPs are expressed at higher levels in patients who have osteoarthritis, rheumatoid 
arthritis or who have damaged cartilage (Nagase et al. 2003).  Thereby the structural 
integrity and mechanical strength of the tissues is impaired, resulting in irreversible 
destruction of the joint structures.  Together, these ECM components are the building 
factors of cartilage and are essential for the construction of regenerative cartilages.  Now 
that the biological materials necessary for cartilage regeneration have been discussed, 
biomaterials used in cartilage regeneration will be described.  
 
2.4 Materials for Hydrogel Fabrication  
Hydrogels are the desired scaffolding for cartilage because the gel offers a similar 
environment for the cartilage cells to grow in compared to the original conditions.  Water 
content within the cartilage generates both mechanical and osmotic pressures which play 
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a significant role in nutrient nourishment and removal of waste products.  These pressures 
affect fluid flow within the cartilage itself and across the articular cartilage 
surface/synovial fluid interface.  Articular cartilage is an avascular tissue i.e., lacks blood 
vessels and hence chondrocytic waste products are eliminated when fluid is extruded 
during compressive loading.  Chondrocytes are subsequently nourished when synovial 
fluid is reinfused into the cartilage during rest.  This reinfusion is driven by osmotic 
pressure differences between the articular cartilage and synovial fluid. 
The main advantage for injectable hydrogels is its ability to be liquid at room temperature 
and will gel at the body temperature.  Hydrogels are hydrophilic polymers that are 
typically crosslinked and consist predominantly of water without dissolution.  Injectable 
hydrogels have been extensively explored more recently because they offer a minimally 
invasive alternative to arthroscopic surgeries and ease of incorporation of cells and 
biologically active agents (Burdick et al. 2001, Kuo et al. 2001, Gobin et al. 2001).  
Hydrogels can be fabricated by a variety of methods and materials including synthetic 
and natural based polymers.  
Synthetic polymers used for hydrogel fabrication come from numerous material sources 
including but not limited to poly(ethylene oxide) (PEO), polyurethane, polyethylene 
glycol (PEG), and poly(vinyl alcohol) (PVA).  Elliseff et al. have used 
photopolymerization to form gels in a fast and controllable manner. Notably, PEO and a 
photopolymerization process have been explored to directly encapsulate chondrocytes 
while transforming a liquid polymer to a gel.  In previous studies, uses of polyurethane 
hydrogels have had difficulty with cell linkage to the scaffold but further exploration with 
the incorporation of diisocynates and poly(ε-caprolactone) with methacrylate end 
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functional groups showed improvement of cellular activity (Werkmeister et al. 2010). 
Another synthetic polymer that has been used with photopolymerization is PEG where 
various blends of bioactive derivatives were used to form a matrix substitute (Mann et al. 
2001).  PVA based hydrogels that have been processed by a freeze/thaw method offers a 
stable hydrogel at room conditions that is highly elastic.  However, many synthetic 
polymers have demonstrated lack of biodegradability in physiological conditions (Lee et 
al. 2001), in addition to regulation of cellular interactions.  Hence, alternative polymers 
are explored for cartilage tissue regeneration.  
Natural polymers from ECM components are utilized as their role in diverse molecular 
mechanisms has been extensively studied.  A natural polymer such as hyaluronan can be 
used as a base material for forming hydrogels.  Research has been done on hyaluronan 
based hydrogels and meshes (Toh et al. 2010).  The hyaluronic acid (HA) hydrogel was 
used for differentiating human embryonic stem cell (hESCs) to produce ECM-enriched 
cartilaginous construct and investigate the hydrogels long-term reparative ability (Toh et 
al. 2010).  Previously, hMSCs encapsulated in alginate hydrogels have been studied to 
observe the chondrogenic differentiation of hMSCs in a gel system to better define 
temporal aspects of relevant gene expression and phenotypic changes (Xu et al. 2008).  
Another polymer often used for hydrogels is collagen.  Collagen is commonly used 
because it is the main component of mammalian ECM tissues such as skin, bone, 
cartilage, tendon, and ligament.  However, collagen hydrogels are limited by their limited 
range of mechanical properties, potential immunogenicity, and can be economically 
undesirable (Lee et al. 2001).   
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2.5 Using Chitosan and Gelatin as Biomaterials in Tissue Engineering 
In this study, chitosan was utilized as the base material for preparing the hydrogels at 
body temperature using β-glycerophosphate (GP) chemistry.  This combination is ideal 
for applications such as drug delivery, cell encapsulation, and injectable tissue 
engineering because the solution maintains a liquid state at physiological pH and gels 
when heated to body temperature.  Interestingly, chondrocytes revealed capabilities of 
maintaining cell viability of eighty percent or more over extended time lengths when 
encapsulated within chitosan-GP in vitro.  Additionally, chitosan-GP gels have been used 
for in vivo purposes and have demonstrated the formation of cartilage after three weeks 
(Ahmadi et al. 2007).  Chitosan was chosen as the base material because it satisfies the 
criteria such as biocompatibility, and biodegradability (Iyer et al. 2011).  Further, it is a 
polysaccharide mimicking the chemical structure of GAGs.  Chitosan is formed through 
the N-deacetylation of chitin, which is an abundant polysaccharide produced by 
crustacean shells, and has repeating units of β(1-4) 2-amino-2-deoxy-D-glucose (Nettles 
et al. 2002).  Additionally, chitosan is capable of being processed into multiple forms 
such as hydrogels without the loss of its functionality but lacks a cell binding domain.  
Chitosan based hydrogels have been blended with ammonium persulfate and N.N.N’.N’- 
tetremethyl ethelenediamine for reduction of gelation time and enzymatic degradation 
(Hong et al. 2006).  Additionally, gelation and degradation rates as well as mechanical 
properties have been explored for chitosan injectable hydrogel derivatives using 
enzymatic crosslinking (Jin et al 2009).  The importance of the cell binding domain 
comes from the necessity of multicellular organisms’ requirement of specific mechanisms 
for intercellular communication and adhesion as well as cell to matrix signaling.  The 
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functional units of cell adhesion are made of three classes of proteins, the adhesion 
receptors, the ECM and the cytoplasmic plaque/peripheral membrane proteins (Gumbiner 
1996).  Thus, an additional material that contains a cell binding domain is necessary for 
the influence of cellular colonization.  Gelatin was chosen due to its binding domain and 
ability to cross link with chitosan without the need of a cross linker.  Also, gelatin is a 
partially denatured derivative of collagen, which is present as a connector for most tissues 
in the body.  The cell binding property of gelatin is contributed by the Arg-Gly-Asp 
(RGD)-like sequence.  Moreover, the linking of chitosan and gelatin results in a structure 
that can affect spatial distribution of integrin ligands and polycationic chitosan interaction 
with the anionic cell surface (Huang et al. 2005).  Additionally, chitosan and gelatin can 
be blended together without a cross linker being present.  Furthermore, recent studies 
have shown that the rheological properties of chitosan-gelatin-β-glycerophosphate (C-G-
GP) are significantly altered when the concentrations are increased.  The gelation 
temperature and time for gelation for the C-G-GP solutions decrease with increasing 
concentrations (Cheng et al. 2010).  A similar article demonstrated similar characteristics 
using collagen or starch instead of gelatin (Song et al. 2010, Ngoenkam et al. 2010).  The 
viability of chondrocytes was measure on the starch containing hydrogels and revealed to 
have an increase in proliferation over a seven day period (Ngoenkam et al. 2010).  Little 
to no mechanical testing for a C-G-GP hydrogel has been done. Alternatively, the 
compressive strength for the collagen and chitosan supplemented with GP has been tested 
and has yielded an elastic modulus in the range of 6-22 kPa (Wang et al. 2010).  In order 
to replicate a sustainable regenerative cartilage, the physical characteristics of the 
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hydrogel needed to be more durable than previous studies to handle the compressive load 
of the body.   
 
2.6 Sources for Chondrocytes 
At first thought, someone may think that chondrocytes from a donor would be the prime 
choice but this is not true.  Monolayer donor chondrocytes gradually lose their phenotype 
and may not for cartilage. Furthermore, the lack of extensive research on immunogenicity 
has been done for the donor cells (Fritz et al. 2009).  However, extensive research has 
been done for stem cells and the results have shown that multiple stem cell lines have the 
capability of producing chondrocytes.  The stem cell lineages for sources that are 
discussed in this study are human embryonic stem cells (hESCs), induced pluripotent 
(iPS) cells, and human mesenchymal stem cells (hMSCs).   
2.6.1 Embryonic Stem Cells: 
Embryonic stem cells are derived from blastocysts from in vitro fertilized human eggs. 
Major advantages for hESCs are their ability to self-renew and differentiate into any cell 
line in the human embryo under proper conditions (Fritz et al. 2009).  On the other hand 
there are many for downfalls to hESCs than benefits.  First, there are legal and social 
issues that arise from their use.  Secondly, there is lack of research covering 
immunogenicity and prevention of teratoma formation in vivo as well as spontaneous 
differentiation upon implantation has occurred for hESCs (Simion,et al. 2010, Fritz et 
al.2009, Tigil et al. 2009).  With the disadvantages outweighing the advantages, another 
cell source must be examined. 
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2.6.2 Induced Pluripotent Stem Cells: 
An alternative idea is to use induced pluripotent stem cells (iPS) with human foreskin 
fibroblasts to yield chondrocytes that can be engineered into a scaffold that will act as 
new cartilage for the knee.  Induced pluripotent stem (iPS) cells have the ability to 
differentiate cells of an abundant source into cells that are either scarce, require a painful 
procedure to get or are expensive to buy from a company.  Adult human cells such as 
fibroblasts can be reprogrammed to a pluripotent state by introducing several 
transcription factors into the adult cell genome with iPS cells (Simion et al. 2010). The 
reprogramming method could be used to derive human iPS cells with properties very 
similar to embryonic stem cells (ESCs) (Takahashi et al. 2007, Yamanaka 2008).  Studies 
in the mouse model demonstrated that iPS cells exhibit properties typical of ESCs 
(Takahashi et al. 2007, Okita et al. 2007, Meissner et al. 2007) and could give rise to 
adult chimeras capable of germline transmission, showing the possibility of 
redifferentiating mature cells.  However, studies have shown that iPS cells have a low 
efficiency of in vitro reprogramming and significant safety considerations to address.  For 
the applicability of the iPS cells in differentiation and clinical applications two major 
hurdles have to be overcome (Okita et al 2007, Meissner et al. 2007, Takahashi et al. 
2006, Blelloch et al. 2007).  Retrovirus-mediated transduction followed by drug-
dependent selection of iPS cells seriously hinder the applicability of iPS cells in 
therapeutic use.  Although some limitations have been addressed by adapting alternative 
experimental protocols (Blelloch et al. 2007, Okita et al. 2008, Nakagawa et al. 2008), 
developing systems without genetic manipulation is necessary.  Alternatively, the RNA 
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in the fibroblasts is rearranged by using methods such as the lentivirus-mediated genetic 
reprograming (Takahashi et al. 2007).   
2.6.3 Mesenchymal Stem Cells: 
Human mesenchymal stem cells (hMSCs) derived from different sources have shown 
capabilities of differentiation into chondrocytes.  The three hMSCs sources explored in 
cartilage regeneration are adipose (AMSCs), amniotic fluid (AFSCs) and bone marrow 
(BMSCs) derived mesenchymal stem cells (Simion et al. 2010).  Adipose tissue is a 
viable and extensive source for AMSCs because of the cells ability to easily expand in 
vitro.  Additionally, protein and mRNA analyses have been done on AMSCs and 
indications of differentiation into chondrocytes were observed.  However, later studies 
have shown that BMSCs have an increased level of chondrogenic markers as opposed to 
AMSCs.  The discovery of AFSCs was an enhancement to the stem cell study due to their 
ease of attainability in large quantities and difference in regulations and standards that are 
set for ESCs.  However, similarly to the adipose derived MSCs, the AFSCs lacked in the 
production amount of cartilaginous matrix when compared to the BMSCs.  Overall, the 
hMSCs have demonstrated viability and potentiality because of their ability to 
differentiate into multiple lineages, namely the chondrogenic lineage.  Furthermore, 
autologous hMSCs are attractive because of the immunogenicity of the cells after 
differentiation in to chondrocytes (Fritz.et al. 2009).  Risk to the donor during extraction 
and risk of disease to allogeneic patients during transmission is a disadvantage to the 
hMSCs.  A major issue with hMSCs is their tendency of progeny to evolve into 
hypertrophic chondrocytes and undergo ossification (Simion et al. 2009).   
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Table 2.1. Advantages and Disadvantages of Sources for Chondrocytes 
Cell Line Cell Source Advantages Disadvantages 
Chondrocytes Autologous (patient) or Allogeneic (donor) 
• Immunogenicity (Autologous) 
 
• Loss of phenotype 
(Allogeneic) 
• Painful procedure 
• Lack of cells 
Human Embryonic 
Stem Cells (hESCs) In vitro fertilized eggs 
• Potential unlimited cell source 
• Self-Renewal 
• Ability to differentiate into any 
cell line 
• Legal and Social Issues 
• Lack of immunogenicity and 
prevention of teratoma 
formation 
• Spontaneous differentiation 
Induced Pluripotent 
Stem Cells (iPS) 
cells 
Adult human cells 
• Ability to differentiate cells from 
an abundant source 
• Economic 
• Less painful procedure for 
acquiring cells 
• Low efficiency of in vitro 
reprogramming 
• Significant safety 
considerations to address 
• Require immune suppressive 
therapies 
Human 
Mesenchymal Stem 
Cells (hMSCs) 
Adipose, amniotic fluid and 
bone marrow as well as other 
sources 
• Multiple sources 
• High viability to differentiate into 
chondrocytes 
• Easily to expand in vitro 
• Immunogenicity (Autologous) 
• Progeny tendency 
• Evolution into hypertrophic 
chondrocytes 
• Possibility of ossification 
• Risk to donor during extraction 
• Risk to allogeneic patient 
during transmission 
Sources: (Simion et al. 2010, Fritz et al.2009, Tigh et al. 2009, Takahashi et al. 2007, Yamanaka 2008, Okita et al. 2007, Meissner et 
al. 2007).   
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The Table 2.1 summarizes the cell sources by their advantages and disadvantages.  Based 
on the advantages and disadvantages the stem cell sources have posed, a novel alternative 
strategy for obtaining chondrocytes has been suggested.  In this study, the Human 
Foreskin Fibroblasts (hFF-1) cell line was used by adopting the same differentiation 
technique as the bone marrow derived hMSCs.  Further discussion of the differentiation 
technique is discussed in the Materials and Methods section (Ch.3 Section 6).  For 
purposes of being concise, only iPSs and bone marrow derived hMSCs differentiation 
techniques are explained below. 
 
2.7 Stem Cell Differentiation to Chondrocytes 
The chondrogenic potential, easy isolation and vigorous proliferation make hMSC the 
attractive candidate cell for cartilage tissue engineering.  hMSCs have been extensively 
investigated to regenerate chondrocytes.  The chondrogenic potential, easy isolation and 
vigorous proliferation make hMSC the attractive candidate cell for cartilage tissue 
engineering.  To induce chondrocyte differentiation, various soluble factors and materials 
making the matrixes on which they are cultivated have been explored.  The use of either 
transforming growth factors (TGF-β) and/or bone morphogenetic proteins (BMPs) is 
common for differentiation of hMSCs into chondrocytes.  Gelatin microspheres 
containing such as TGF-β3 is shown to promote hMSC differentiation to chondrocytes 
(Fan et al. 2008).  Another process for differentiation into cartilage cells comes by 
treating the stem cells with bone BMPs with the addition to chondrogenic medium (Gong 
et al. 2010).   
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Many have reported multiple comparison analyses using cells harvested from single 
cartilage biopsy specimens (Grogan et al. 2007), hMSC differentiation into chondrocytes 
on alginate cultures (Lee et al. 2009).  The Sox 9 gene expression is a measurable 
variable for the stem cells whereas Aggrecan, Collagen Types I and II and osteopontin 
(OPN) are measured for the chondrocytes (Gong et al. 2010).  Cells with greater 
chondrogenic capacity expressed higher levels of a number of surface molecules, all 
known to play a key role in mesenchymal condensation (Goldring et al. 2006).  These 
included the hyaluronan receptor CD44, the tetraspanin CD151 and α3 integrin (CD49c).  
CD151 is expressed at high levels in hMSCs and CD44 is a well-known marker for 
hMSCs.  As the culture continues to grow the appearance of the stem cell diminishes with 
time; this is due to the stem cell line having successful differentiation into cartilage cells.  
Cells with higher chondrogenic capacity express lower levels of catabolic mediators and 
higher levels of surface molecules involved in the early stages of cartilage development, 
including those involved in establishing cell–cell and cell–matrix interactions (e.g., the 
hyaluronan receptor CD44 and the tetraspanin CD151).  However, the expression level of 
CD151 was not significantly changed from that of MSCs without TGF-β3 but was 
reduced reversibly by TGF-β3 treatment during the 3-D alginate culture and that of CD44 
decreased reversibly by the 3-D alginate culture alone and irreversibly in the presence of 
TGF-β3 (Lee et al. 2009). 
MSCs cultured in a pellet or on micromass or on a three-dimensional scaffold have been 
shown to differentiate into chondrocytes more efficiently than individual cells.  Cell 
density is one of the critical requirements for stabilizing the chondrocyte phenotype.  In 
monolayer culture, chondrocytes usually devolve into fibroblastic morphology and 
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secrete collagen I.  The phenotypic instability in monolayer culture makes the pellet 
culture a useful method to engineer cartilage.  When chondrocytes are cultured at a high 
cell density, the phenotype is kept.  Compared to other three-dimensional cultures, such 
as hMSCs cultured on micromass or a scaffold, the advantages of pellet culture are:  
(1) the chondral phenotype is stabilized in pellet, and  
(2) the cartilage is engineered without additional materials, which may induce 
immune-inflammatory reactions.  
The hMSCs pellet cultured in chondrogenic differentiation medium shares similarities 
with native cartilage in cell distribution and matrix composition.  Furthermore, 
spontaneous chondrogenic differentiation of MSCs in a pellet can occur without addition 
of any other bioactive stimulators.  The cell pellet has been used to construct hyaline 
cartilage, repair chondral defects, and enhance the healing of the bone−tendon junction.  
Although excellent outcomes are reported, the limitations such as inadequate size and 
poor process ability are associated with the conventional cell pellet. So there is a potential 
need to optimize the hMSCs pellet culture for enhancing the chondrogenesis of pellet. 
The main variable that is tested for though is Collagen Type II, which is secreted from 
the cells when they are going through the stages of mitosis.  From previous studies, a 
chitosan-gelatin mixture has been found to support cell proliferation and viability of skin 
cells.  Additionally, the shape of the cells encapsulated in the hydrogels was observed to 
closely resemble chondrocytes.  As for the evaluation of chondrogenic cell viability 
within hydrogels, Toh et al. used a hyaluronan based hydrogel to measure the amount of 
Collagen Type II that is secreted from the cells.  The group compared the environment 
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effects of the gel to that of a cellular pellet.  Superior chondrogenesis indicated by 
significant higher levels of s-GAG and Type II collagen was observed in the hydrogel 
system (Toh et al. 2010).  The hydrogel offered a more suitable environment to support 
cell growth for chondrocytes than the pellet system for both sGAG/DNA as well as Type 
II collagen/DNA.  The limitations that have been associated with regenerating a suitable 
cartilage replacement useable at clinical setting are the motivation for this study.  
Therefore in short the variables that are examined in this work is the mechanical strengths 
of varying chitosan gelatin concentrated hydrogels and size and shape factor, Collagen 
Type II, histology and flow cytometry analyses for the hFF-1 and hMSC pellet and 
hydrogel systems. 
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CHAPTER III 
 
 
METHODOLOGY 
 
3.1 Sources for Materials 
Low molecular weight (LMW) chitosan (200-300 kDa and 75-85% deacetylation), 
Gelatin Type A (300 Bloom), Glycerol 2-phosphate (G2P), and Bovine Serum Albumin 
(BSA) were purchased from Sigma Aldrich Co. (St. Louis, MO).  Hydrochloric acid 
(HCl) and ethyl alcohol (EtOH) (200 proof) were obtained from Pharmco.  Formalde-
Fresh (certified low odor 10% Formalin) was obtained from Fisher Scientific (Pittsburgh, 
PA).  Phosphate buffered saline (PBS), Trypsin/EDTA (0.25% Trysin-0.53 mM EDTA 
solution), ATCC-formulated Dulbecco’s Modified Eagle’s Medium (DMEM), and ATCC 
tested fetal bovine serum (FBS) was purchased from American Type Culture Collection 
(ATCC) (Manassas, VA).  Clonetics Trypsin-EDTA for human Mesenchymal Stem Cells 
(hMSC), Fibroblast Basal Medium (FBM) supplemented with Fibroblast Growth 
Medium (FGM) SingleQuot Kit and Growth Factors, Mesenchymal Stem Cell Basal 
Medium (MSCBM) supplemented MSC Growth Medium SingleQuots, Chondrogenic 
Basal Medium supplemented with hMSC Chondrogenic SingleQuots Kit and 
Transforming Growth Factor Beta 3 (TGF-β3) were attained from Lonza Walkersville, 
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Inc. (Walkersville, MD). Mouse Anti Human CD151: FITC and Mouse Anti Human 
CD44: RPE were purchased from MorphoSys US Inc. (Raleigh, NC).  Collagen Type II 
ELISA was acquired from MD Bioproducts Division of MD Biosciences, Inc. (St. Paul, 
MN).  5-(and-6)-carboxyfluorescein diacetate, succinimidyl ester (5(6)-CFDA, SE; 
CFSE) - mixed isomers was obtained from Invitrogen Corp. (Carlsbad, CA). Matrix 
metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) fluorogenic 
peptide (DNP-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH) and matrix metalloproteinase 13 
(MMP-13) fluorogenic peptide (MCA-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH2 [Cha = L-
cyclohexylalanine; Dpa = 3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl; Nva = L-
norvaline] was purchased from CalBiotech (Spring Valley, CA). 
 
3.2 Hydrogel Formulation and Formation 
Chitosan-gelatin mixture at a concentration at a desired concentration (0.5%-0.5% w/v or 
2%-1% w/v or 2%-2% w/v was autoclaved in DI water.  One normal diluted HCl was 
added to dissolve the chitosan in the solution and allowed to stir overnight.  For preparing 
0.5%-0.5% chitosan-gelatin solution, one mL of G2P at 0.56 g/mL concentration was 
added drop wise into 9 mL of the solution in an ice bath to adjust the pH.  For higher 
concentrations, 4 mL of the G2P solution was added drop-wise to nine mL of chitosan-
gelatin solution kept in an ice bath in the laminar hood.  Solution should be kept in an ice 
bath while adding the G2P solution and continuous stirring are necessary to avoid 
precipitation. 
To prepare the hydrogel system, 0.5 mL of solution was added to either an hFF-1 or 
 hMSC pellet in a 15 mL polypropylene culture tube, as described in the following 
sections.  Soon after, the solution and pellet system was supplemented with the medium 
specific to the cell line; this was done by allowing the medium to flow down the side of 
the tube and using the fluid properties of the two solutions to not induce mixing. 
system was incubated at 37°C and 5% CO
formed after approximately 
through the pores in the hydrogel.
Figure 3.1. Flow chart for chitosan
concentration was 0.5%/0.5% and 2%/1% w/v for cell culture systems and 2%/0%, 
2%/1%, and 2%/2% w/v for rheology and mechanical testing.
 
3.3 Rheology and Compression 
Viscous modulus and elastic modulus at various temperatures were evaluated using 1.5 
mL solution in a Bohlin CVO c
Brunswick NJ).  Analysis was performed at 1 Hz shear rate
Compression testing was done on the hydrogels systems by using 
machine (INSTRON, Canton, MA)
size exactly matching the custom
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formed on the bottom anvil by incubating 5 mL solution at 37oC in an oven.  The 
dimensions of the hydrogel were 25 mm in diameter with a depth of 7mm and circular 
geometry.  The top anvil was also incubated in an oven at 37°C saturated with water.  
Hydrogel was formed on top of the anvil by creating a well, as shown in Figure 3.2.  
Hydrogels were compressed at 1 mm/min crosshead speed, similar to previous reports.  
Using the associated Merlin (INSTRON, Canton, MA) software, data were recorded.  
The elastic modulus was calculated from the slope of the linear portion (0.1% to 0.3% 
strain range) of the stress-strain curve.   
 
Figure 3.2. Custom made top and bottom compression testing anvils with hydrogel 
chamber used on the INSTRON 5542 machine.  
 
 
 
29 
 
3.4 Cell Population Maintenance 
Human Foreskin Fibroblasts (hFF-1) cell line was purchased from ATCC (Walkersville, 
MD) and maintained in ATCC-formulated DMEM supplemented with 15% ATCC tested 
FBS (ATCC, Walkersville, MD).  Cells were incubated at 37°C and 5% CO2/95% air 
atmosphere and medium was changed every 2 days.  Cells were frequently monitored for 
shape and confluency.  Once confluent, the hFF-1s were detached with Trypsin/EDTA 
(0.25% Trysin-0.53 mM EDTA solution) (ATCC, Walkersville, MD).   
Adult hMSC cell line was purchased from Lonza Walkersville, Inc. (Walkersville, MD) 
and maintained in MSCBM supplemented with MSCGM supplementation (Lonza 
Walkersville, Inc., Walkersville, MD).  Both cultures were incubated at exhibited normal 
growth characteristics with respect to size, shape and confluency.  Cells were incubated 
at 37°C and 5% CO2/95% air atmosphere and medium was changed every 3 to 4 days.  
Once confluent, the hMSCs were detached with Clonetics Trypsin-EDTA (Lonza 
Walkersville, Inc., Walkersville, MD).   
They were then stained with CFDA-SE, which is an amine-reactive, colorless, non-
fluorescent dye that passively diffuses into the cytoplasm of the cells.  250,000 cells were 
seeded into the controls and hydrogels of each group, as described below. 
 
3.5 Cell Morphology Analysis 
Cells cultured on tissue culture plastic and after treatment with trypsin/EDTA were used 
for initial morphology analysis.  Digital micrographs were captured at various random 
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locations through an EVOSTM AME-i2111 digital inverted microscope (Advanced 
Microscopy Group, Bothell, WA).  These images were quantified for cell shape factor 
(also called circularity factor and defined as 4π × area/perimeter and when the number is 
closer to 1 the cell shape is closer to that of a circle) and cell area using image analysis 
software Sigma Scan Pro (SPSS Science, Chicago, IL).  For each condition, more than 50 
cells were analyzed using many micrographs acquired randomly.  Box plot showing the 
distribution of shape factor and area of cell with 10th, 25th, 50th, 75th, and 90th percentiles 
and the mean value (thick line within each box) were plotted.  Values that were outside 
95th and 5th percentiles were treated as outliers.   
 
3.6 Cell Pellet and Suspension Cultures 
Cells were tested in three culture conditions in the pellet and suspension cultures and are 
represented in a concise manner in the figure below.   
i) hMSC cell line in complete chondrogenic induction media, serving as the 
positive control group, 
ii) hFF-1 cell line in complete chondrogenic induction media, serving as the 
experimental test group and  
iii) hFF-1 cell line in Fibroblast Basal Medium (FBM) supplemented with 
Fibroblast Growth Medium (FGM) SingleQuot Kit and Growth Factors, 
serving as the negative control group.  
For the chondrogenesis culture protocol, incomplete and complete chondrogenic 
induction media were prepared prior to cell culturing.  Incomplete medium was 
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formulated by supplementing the Chondrogenic Basal Medium with hMSC 
Chondrogenic SingleQuots Kit.  The Complete Chondrogenic Induction Medium was 
prepared by supplementing the incomplete medium with the TGF-β3 solution to a final 
concentration of 10 ng/mL (Lonza Walkersville, Inc., Walkersville, MD).  The TGF-β3 
solution was prepared by suspending the lyophilized TGF-β3 in 4mM HCl supplemented 
with 1 mg/mL bovine serum albumin (BSA) to a concentration of 20 µg/mL.  The 
Complete Chondrogenic Medium (CCM) was prepared fresh before each usage due to the 
 Table 3.1. Experimental and Control Variables using h
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short shelf life of 12 hours.  Cells were washed with PBS and detached using the 
respective Trypsin/EDTA solution.  Respective cell line medium was used to wash the 
plate and neutralize the Trypsin/EDTA.  The cell suspension was centrifuged for 5 
minutes at 270×g for hFF-1s and 600×g for hMSCs, resuspended in medium and counted 
using a hemacytometer.  CFDA-SE was added to the cell suspension at a volume ratio of 
1:100 and incubated for 20 minutes.  Cells were aliquoted at 250,000 cells per culture and 
centrifuged at 150×g for 5 minutes in 15-mL centrifuge tubes.   
For chondrogenesis cultures, positive control and experimental groups, the medium was 
removed and the cells were washed and resuspended with 0.5 ml of Incomplete 
Chondrogenic Medium (ICM).  The cells were centrifuged once more at 150×g to form 
the pellet and the ICM was removed.  For the control system, 0.5 ml of Complete 
Chondrogenic Medium (CCM) was added carefully to not disturb the pellet.  For the 
hydrogel system, 0.5 mL of the chitosan-gelatin/ glycerol 2-phosphate solution was 
added carefully and 0.5 mL of CCM was added on top of the solution.  The caps of the 
tube were loosened one half turn to allow for gas exchange.  The cell pellets were 
incubated at 37°C and 5% CO2 in air atmosphere and were not disturbed for 24 hours.  
Medium was changed twice a week by completely replacing the medium in the tube with 
freshly prepared CCM.  The bottom of the tubes was flicked to release the pellet at the 
time of the first medium replacement.  Culture supernatants were preserved at -80°C for 
Collagen Type II analysis.  The chondrogenic pellets were harvested after 28 days and 
analyzed via histology.  
For the hFF-1 negative control group, the same procedure was followed except washing 
and incubating in FGM was used to wash and culture cells.  Quantities of hydrogel 
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solution and medium and medium replacement process were similar to the Chondrogenic 
cultures.  Supernatants and harvesting was done for the negative control group as well.  
Suspension cultures were prepared using the same conditions and quantities as previously 
described.  After the final centrifugation, the cells were resuspended for the controls as 
well as the hydrogels.  The hydrogels in this case were prepared at a concentration of 
2%/1% chitosan-gelatin solution.  This was done for the positive and negative control 
groups and the experimental group.  Supernatants of the cultures were preserved for 
indirect quantification of cell viability within the matrix. The controls were centrifuged at 
150×g in order to remove the supernatants and resuspended in fresh medium.  The pellets 
were harvested after 7 days in culture for histological processing and examination.    
 
3.7 Collagen Type II ELISA  
Preserved supernatants from the cell pellet culture were tested for the production of 
Collagen Type II using ELISA kit from MD Bioproducts Division of MD Biosciences, 
Inc. (St. Paul, MN).  The supernatants were thawed to room temperature (22°C - 25°C) 
and centrifuged before using.  The standards for the ELISA were prepared using vendors 
protocol (300, 150, 75, 37.5, 18.8, 9.4, 4.7 ng/mL).  In brief, 700 µL of Assay Diluent 
was pipetted into the 300 ng/mL standard tube and 500 µL of Assay Diluent into the 
remaining standard tubes.  300 µL of the 1000 ng/mL standard was added to the 300 
ng/mL tube to produce a dilution series.  Once the standards were prepared, the 
microplate was loaded with the standards and the samples at 100 µL/well in duplicate.  
The plate was sealed and allowed to incubate at room temperature for 2 hours.  The Wash 
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Buffer was prepared by diluting 50 mL of Wash Buffer Concentrate in 450 mL of DI 
water.  The Conjugate was made by diluting 110 µL of Conjugate Concentrate in 11 mL 
of Conjugate diluent.  After 2 hours, the plate was aspirated and washed six times with 
200 µL/well with the Wash Buffer. The wells were filled and emptied at each wash and 
the plate was blotted on paper towels to remove and residual fluid.  100 µL of the 
Conjugate was pipetted into each well and the plate was covered and allowed to incubate 
for 2 hours.  Due to a 30 min shelf life, the Streptavidin-HRP was prepared by adding 
110 µL of Streptavidin-HRP Concentrate to 11 ml of HRP Diluent and kept from light 
with 5 minutes left in the 2 hour wait time.  The wells were aspirated, washed and blotted 
as previously mentioned and 100 µL of the diluted Streptavidin-HRP was added to each 
well.  The plate was covered and incubated in the dark for 30 minutes.  The wells were 
once more aspirated, washed and blotted and 100 µL of Substrate was pipetted into each 
of the wells.  The plate was covered, incubated and protected from light for 20 minutes.  
After 20 minutes, the reaction was stopped by adding 100 µL of Stop Solution to each 
well.  The side of plate was tapped gently to ensure mixing and the plate was read for 
absorbance at 450 nm using a Molecular Devices EMax Precision Microplate Reader 
(Molecular Devices, LLC, Sunnyvale, CA).  Data was collected using the associated 
Softmax Pro software.  
 
3.8 Flow Cytometry Analysis 
Cells were trypsinized, counted, and divided into two groups (~1 x 105 cells/group) : i) 
control group and ii) analysis group.  Then cells were centrifuged for 6 minutes at 270×g, 
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washed in phosphate buffered saline (PBS) containing 1% bovine serum albumin (BSA), 
and centrifuged for 6 minutes at 270×g.  Cells were then labeled with monoclonal 
antibody against FITC conjugated mouse-anti human CD151 (AbDseortec) and RPE 
conjugated mouse-anti human CD44 (AbDseortec) and incubated for 30 to 60 minutes in 
the dark at 4°C. Cells were then washed in 5 ml of PBS–1% BSA and centrifuged for 6 
minutes at 270×g.  Pellets were finally resuspended in 200µL PBS/1% BSA, and the 
resulting cell suspension was analyzed using a Becton Dickinson FACS Calibur flow. 
 
3.9 Histology Analysis  
The pellets from the controls and the hydrogels were harvested after 28 days and fixed 
with 3.7% formaldehyde for 30 minutes at room temperature.  The samples were washed 
three times with PBS and stored in absolute ethanol overnight at 4°C.  The samples were 
sectioned and stained for Haematoxylin and Eosin (H&E), Masson’s trichrome, and 
Alcian blue stain at 2.5 pH.  
For the suspension cultures, the quantities and conditions remained constant.  The 
controls were centrifuged to obtain a pellet culture and the process for harvesting pellet 
cultures was followed.  The hydrogel cultures were left in suspension and fixed with 
3.7% formaldehyde for 30 minutes at room temperature.  Control and hydrogel cultures 
were washed thrice with PBS and stored in absolute ethanol overnight at 4°C.  These 
samples were sectioned at 4µm thickness and stained by Oklahoma Animal Disease and 
Diagnostic Laboratory (OADDL) with the same stains as previously mentioned.  
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3.10 MMP-2/MMP-9 and MMP-13Analysis  
Matrix metalloproteinase activity in the supernatants and fresh media was examined to 
understand the phenotypic changes in the cells.  The activity was measured using 
fluorogenic substrates (DNP-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH) and (MCA-Pro-Cha-
Gly-Nva-His-Ala-Dpa-NH2 [Cha = L-cyclohexylalanine; Dpa = 3-(2,4-dinitrophenyl)-L-
2,3-diaminopropionyl; Nva = L-norvaline] specific for MMP-2/MMP-9 and MMP-13, 
respectively.  Concisely, 100μL of a 100μM fluorogenic peptide/DMSO solution was 
added to 100μL of cell supernatant and incubated at 37°C for 20 minutes.  Then, the 
fluorescence was measured at 320nm excitation and 405nm emission Molecular Devices 
SpectraMax Gemini XS Precision Microplate Reader (Molecular Devices, LLC, 
Sunnyvale, CA), as described previously (Iyer et al. 2011).   
 
3.11 Statistical Analysis  
Statistical analysis was performed by repeating experiments three or more times and 
collecting samples in triplicate. A one way analysis of variance (ANOVA) with a 99% 
confidence interval was used for evaluation for significant differences between two 
groups.  Differences were considered statistically significant when p<0.05. 
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CHAPTER IV 
 
 
RESULTS AND DISCUSSION 
 
4.1 Decreased Thermal Gelation with Increased Hydrogel Concentration  
The gelation temperature is the temperature at which the hydrogel begins to form.  When 
rheological tests are performed, the gelation point is determined to be the temperature 
where the elastic modulus increases significantly and may cross the viscous modulus of 
the hydrogel.  Previous studies have showed that addition of 2-glycerophosphate (2GP) 
into 0.5% w/v chitosan solution creates a solution at room temperature (or at 4oC) and 
converts into a semisolid gel at body temperature.  However, the elastic modulus of the 
0.5% w/v chitosan hydrogel is significantly weaker than that of cartilage, and cannot be 
utilized in cartilage repair.  Further, using chitosan alone is not favorable as there are no 
cell adhesive sites in the polymer.  Hence, addition of gelatin to chitosan was tested for 
gel formation with equal polymer concentration.  Presence of gelatin at 0.5% w/v 
concentration in chitosan did not alter the hydrogel formation at body temperature and in 
fact, the gelation temperature showed a reduction (Figure 4.1 B).  Others have observed 
similar reduction in gelation temperature of chitosan with the addition of other polymers 
(Ngoenkam et al. 2010).  However, addition of gelatin at similar concentration showed no 
significant improvement in mechanical properties.   
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To improve the mechanical properties, polymer concentration was increased to 
2% w/v.  Rheological analysis indicated (Figure 4.1 A) that the gelation is 
achievable at a lower temperature (15-20oC) with the more concentrated polymer 
solution.  This reduction in gelation temperature is advantages in the clinical 
settings as it ensures safe formation of hydrogel at body temperature and complete 
maturation of the interpenetrating polymer network.  Further significant 
improvement in elastic modulus was observed relative to 0.5% w/v chitosan 
solution.  Others have reported that increasing the concentration of chitosan also 
increases the rate of gelation (Cheng et al. 2010).  Analysis of the porous 
architecture of chitosan based hydrogels with similar concentrations has also been 
performed using scanning electron microscopy.  Chitosan-collagen-G2P 
hydrogels showed spongy porosity with open pore architecture, suitable for the 
diffusion of nutrients to the entrapped cells.  Hydrogels containg only chitosan 
revealed loose, irregular and larger pore diameters wheras, the collagen only 
based hydrogels exhibited an interconnected fibrous network (Song et al. 2010, 
Wang et al. 2010).  This difference can be attributed to the presence of collagen to 
stabalize the scaffold after the polymerization of chitosan (Song et al. 2010).  
Thus, the increased concentration of chitosan and gelatin could be utilized in the 
cartilage regeneration.  
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Figure 4.1. Thermal gelation temperature of chitosan-gelatin hydrogels. (A) 2% Chitosan-2% Gelatin.  (B) 0.5% Chitosan-0.5% 
Gelatin. 
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4.2 Improved Strength and Elasticity of Hydrogels 
The elastic modulus for articular cartilage ranges from 0.35 to 2.0 MPa (Werkmeister et 
al. 2010).  Hence the hydrogels with similar mechanical properties are required for 
clinical utilization in cartilage repair.  To understand the improvement in the mechanical 
characteristics of the hydrogel, compression testing was performed on preformed 
hydrogels.  Since the hydrogels are reversible to liquid form, testing was performed at 
body temperature.  The chitosan-gelatin concentrations tested for improved compressive 
loading strength were 2%/0%, 2%/1%, and 2%/2%.  These results showed (Figure 4.2 A) 
significant improvement in the ultimate stress although strain range decreased with 
increased polymer concentration.   
Alterations in mechanical characteristics were further analyzed by determining the 
compressive for each concentration assuming Hook’s law.  Linear region was chosen in 
the stress-strain curve and the slopes were determined.  These results (Figure 4.2 B) 
showed modulus values in the range of 15 to 40 kPa for 2% w/v chitosan with and 
without gelatin.  This is a significant improvement relative to 0.5 % w/v chitosan which 
was in the range of 0.01 to 0.02 kPa.  Addition of 1% w/v gelatin to chitosan increased 
the compressive modulus moderately and increasing gelatin to 2% w/v did not show 
significant difference with 1% w/v gelatin.  Hence, 2%-1% chitosan-gelatin was chosen 
for further cell culture analysis.  Also, gelation was observed with 2%-2% chitosan-
gelatin solutions while forming sterile solutions and could not be used in seeding cells.  
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Figure 4.2. Mechanical compression testing of hydrogels.  (A) Conventional True Stress - True Strain diagram for 2%/0%, 2%/1%, 
and 2%/2% w/v chitosan-gelatin hydrogels.  (B) Elastic Moduli of the 2%/0%, 2%/1%, and 2%/2% w/v chitosan-gelatin hydrogels. 
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4.3 Size and Shape Factor Analysis 
The objective of the study was to explore hFF-1 as an autologous cell source relative to 
hMSCs.  To understand the difference in the two cell types, their spreading 
characteristics and shape factors (also called circularity factor) were analyzed when 
attached to tissue culture plastic and when suspended in a liquid medium.  Micrographs 
were obtained from cell cultures at random time points to assess spreading during 
adhesion.  These results (Figure 4.3) showed that hMSCs spread significantly larger than 
hFF-1s.  The shape factor (also called circularity factor) analysis indicated that their 
shapes were similar when attached to the tissue culture plastic.  Both cell types showed 
significant deviation from the round shape observed in naturally occurring chondrocytes.   
Since the round morphology of chondrocytes could be attributed to weak adhesion to a 
substrate, morphology of cells were assessed when the cells were detached from the 
surface.  Also, hydrogels provide three-dimensional space unlike tissue culture plastic 
and for better analysis of the outcome of culturing hFF-1s and hMSCs, knowing the cell 
area in suspension was important.  These results showed significant reduction in the cell 
size when suspended and the shrinkage in hMSCs was much higher than hFF-1s.  
Further, hFF-1s showed increasing cell size relative to hMSCs.  Interestingly, both cell 
types showed similar shape and approached that of circular cells.  
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Figure 4.3. Size and shape factor for hFF-1 and hMSC lineages on day zero.  (A) Size analysis when attached to the tissue culture 
plastic (TCP).  (B) Size analysis when suspended in serum containing medium (hFF-1) and MSCBM (hMSC).  (C) Shape factor 
analysis when attached to the tissue culture plastic (TCP).  (D) Shape factor analysis when suspended in serum containing medium 
(hFF-1) and MSCBM (hMSC).   
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4.4 Analysis of Collagen Type II Secretion  
Cells were cultured by adapting a system utilized for hMSC differentiation into 
chondrocytes with and without different concentrations of chitosan-gelatin hydrogels for 
a week.  The hallmark of chondrocyte differentiation is the production of collagen type II 
instead of collagen type I production by fibroblasts.  Hence, to understand whether 
fibroblasts could be converted to chondrocytes is to assess the production of collagen 
type II.  Hence the phenotypic change leads to an altered biosynthesis of matrix proteins, 
increasing synthesis of collagen type II instead of collagen type I.  The collagen content 
was measured in the supernatants harvested at different time points up to twenty eight 
days.  The negative control group is the hFF-1s cultured in the pellet form in serum free 
medium.  The positive control group was the hMSCs and experimental group was the 
hFF-1s in complete chondrogenic differentiation medium, respectively.  The collagen 
secretion from the hMSCs in the pellet system gives a baseline reading for comparison 
with the negative and experimental groups.  Both negative and experimental groups 
showed similar trend relative to the hMSCs in the pellet system (Figure 4.4 A) and were 
significantly less than hMSCs in all measured time points.  This suggested no significant 
change in phenotypic expression of hFF-1s due to the soluble factors alone, unlike the 
hMSCs.  
Next, the effect of hydrogel system was compared for changes in Collagen type II 
secretion.  hMSCs showed an increase in collagen type II production relative to the 
system without the hydrogel (Figure 4.4 B).  These results are consistent with previous 
studies that have shown collagen type II levels to increase presence of hyaluronan based 
hydrogels than in the pellet culture systems (Toh et al.2010).  Interestingly, the hydrogel 
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Figure 4.4. Collage Type II secreted into the medium throughout the 28 day culture period.  (A) Pellet system for hFF-1control 
group and hFF-1s and hMSCs in differentiation medium.  (B) Hydrogel system for hFF-1 control group and hFF-1s and hMSCs in 
differentiation medium. 
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systems containing hFF-1s showed a significant increase in collagen type II, comparable 
to that hMSCs.  The negative control group showed a significant increase on day 7 
relative to other cultures, which significantly decreased by day 14 and day 21.  On the 
contrary, the experimental group showed a significant increase at day 21.  When 
comparing the pellet system to the hydrogel system, the amount of collagen secreted into 
the supernatant was higher for all groups in the hydrogel system.   
In the hydrogel system, gelatin was mixed with chitosan and it could be questioned that 
the observed increase in all hydrogel cultures could be attributed to confounding factors 
in the ELISA.  Hence, further analysis was performed at day 4 and day 7 to understand 
whether the increase is due to gelatin leaching and non-specific detection by the analysis.  
For this purpose, collagen content in the fresh medium and the medium exposed to 
hydrogels without cells were collected after four and seven days.  Since hFF-1 negative 
control was incubated in Fibroblast Basal Medium (FBM), and hFF-1 experimental group 
and hMSCs were incubated in complete chondrogenic differentiation medium (CCM), 
both were also analyzed.  Further, hFF-1s and hMSCs were propagated in two different 
media i.e., serum containing media and Mesenchymal Stem Cell Basal Medium 
(MSCBM).  They were also analyzed for comparison. 
Figure 4.5 demonstrates a significant quantity of collagen that is contained in the, when 
compared with the FBM, serum free medium, and the CCM.  The same is true for the 
hydrogel and medium only systems that were cultured up to day seven.  Furthermore, the 
amount of collagen in the medium decreased from the fresh medium to that exposed to 
hydrogels at both time points.  The reduction in collagen type II content suggested that 
the observed increase in the hydrogel cultures is not due to non-specific leaching and 
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detection by the assay system.  Therefore, the increase in the day seven hydrogel cell 
cultures in Figure 4.4 B is not attributed to leaching of gelatin.  The inferences that can 
be drawn from the ELISA results are that, collagen type II is consistently secreted by 
each of the groups in both pellet and hydrogel systems, secreted in higher amounts in the 
hydrogel systems when compared with the pellet system.   
Incubation did decrease the collagen type II content in the medium, which can be 
attributed to the stability of the protein at 37°C and liquid environment as seen in Figure 
4.5.  Also, all pellet cultures showed a reduction relative to the media that was incubated 
for seven days in hydrogels alone in the absence of cells.  Hydrogels with cells exhibited 
an increase in collagen type II for all cultures during the culture period. 
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Figure 4.5. Collagen Type II content in serum containing medium, MSCBM, FBM, 
and CCM for fresh medium (day zero) and medium supernatants of hydrogel 
systems without cells for first change (day four) and second change (day seven). 
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4.5 Alterations of CD44 PE and CD151 FITC Expressions on Hydrogel Systems.  
Hydrogel systems showed better collagen type II secretion relative to without hydrogels.  
These changes could be attributed to the cell-matrix interactions, either that present in the 
matrix or synthesized by the cells.  CD151 is a member of tetraspanins, which are 
membrane proteins that bind to laminin-binding integrins and other proteins to generate 
functional complexes involved in cell–cell and cell–ECM interactions.  The major 
receptor for hyaluronan, CD44, is highly expressed during MSC condensation and plays 
an important role in chondrogenesis.  These receptor expression changes were measured 
in all cells after seven day cultures.  Similar to literature results, CD151 was expressed at 
high levels in hMSCs and hFF-1s (Geary et al. 2008).  The 0.5% gel had (Figure 4.7) 
little to no change from the unstained control, whereas the 2%/1% chitosan-gelatin 
hydrogel had an up-regulation for both CD44 PE and CD151 FITC.  This is significant 
because as the chitosan-gelatin concentration increases there is higher reception of 
hyaluronan and laminan, which suggests differentiation of the HFF-1s.  In partial 
similarity, the hMSC pellet system had an up regulation of CD44 PE but followed the 
same trend as the unstained control for CD151 FITC.  During wound healing, CD151 
expression is upregulated within the first week in the epidermis and delayed wound 
healing is observed in the null CD151 mice (Cowin et al. 2006).  The altered expression 
of CD44 in high-chondrogenic-capacity cells is consistent with a recent report of up-
regulation of CD44 on human chondrocytes expanded on type II collagen–coated dishes; 
these chondrocytes exhibit a superior capacity to generate cartilaginous tissue (Barbero et 
al. 2006).  Decreased CD44 expression of hMSCs reversibly on 3-D alginate culture 
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alone and irreversibly in the presence of transforming growth factor TGF-β3 has also 
been reported (Lee et al. 2009).  Alterations in CD151 are not related to alterations in 
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Figure 4.6. Flow cytometric histograms of CD44 PE and CD151 FITC stained hFF-1s and hMSCs in CCM on Day 7.  (A) 
CD44 PE stained hFF-1s cultured in 0.5%/0.5% w/v chitosan-gelatin hydrogel.  (B) CD44 PE stained hFF-1s cultured in 2%/2% w/v 
chitosan-gelatin hydrogel.  (C) CD44 PE stained hMSCs cultured in pellet form.  (D) CD151 FITC stained hFF-1s cultured in 
0.5%/0.5% w/v chitosan-gelatin hydrogel.  (E) CD151 FITC stained hFF-1s cultured in 2%/2% w/v chitosan-gelatin hydrogel.  (F) 
CD151 FITC stained hMSCs cultured in pellet form  
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CD44 in fibroblasts (Liu et al. 2007).  Others have reported multiple comparison analyses 
using cells harvested from single cartilage biopsy specimens (Grogan et al. 2007), MSC 
differentiation into chondrocytes (Lee et al. 2009, Goldring et al. 2006).  Thus further 
analysis is necessary to confirm chondrocyte differentiation.  
 
4.6 Evaluation of Tissue Morphology and Collagen  and GAG Distribution of Tissue 
Cellular morphologies and the distribution of collagen and glycosaminglycan were 
evaluated to understand the quality of the regenerated tissue as well as differentiation of 
the positive and experimental groups.  In the negative control pellet culture without the 
hydrogel, the cell number and amount of ECM compontents in hFF-1s were much lower 
and the tissue size was also significantly smaller on the twenty eighth day as seen in 
Figure 4.7 A-C.  The tissue size was less than one millimeter for the hFF-1 pellets 
without hydrogels and 4 mm for the hFF-1 pellet- hydrogels.  Higher magnifications of 
this pellet culture displayed packed cells with minimal ECM.  This was confirmed by 
Trichrome (for collagen) and alcian blue stains (glycosaminoglycans).  Thus the 
increased collagen type II released from these cultures could be attributed to the lack of 
space for the organization of the matrix element.   
Haematoxylin and Eosin (H&E) staining was used to stain the cell nucleus and the matrix 
in the tissue; cell nucleus and the matrix are stained blue and pink, respectively.  In 
comparison of each of the groups stained with H&E, the positive and experimental 
groups showed similar distribution of cells and matrix elements (Figure 4.8 B-F).  
However, the tissue harvested from negative control (hFF-1 cultured on hydrogel with  
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Figure 4.7.  hFF-1 Negative Control Pellet culture without hydrogel on day 28.      
(A) Haematoxylin and Eosin stain.  (B) Masson’s Trichrome stain.  (C) Alcian Blue stain 
(pH 2.5). 
 
the FBM) was significantly less dense than the other two groups.  Further, cells were 
sparcely dispersed, unlike cell clustures surrounded by matrix elemenets or sparcely 
dispersed cells in dense matrix components in both hFF-1 and hMSC cultures incubated 
in CCM.  In experimental group of hFF-1 and hMSC cultures histological appearance 
were similar; both cultures showed round morphology of cells with increased nuclear size 
relative to the cytoplasm, an indication of chondrocytes.  The primary difference was the 
size of each cell with hFF-1 cultures showing small size relative to hMSCs (Figure 4.8 
(A) 
(B) (C) 
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B,C,E,F).  This could be attributed to the initial cell sizes.  Very few cells were noticed in 
the negative control group suggesting reduced cell viability (Figure 4.8 D).  
To understand the various elements within the matrix, tissue sections were stained with 
Masson’s Trichrome stain to evaluate the amount and the distribution of mature collagen 
surrounding and within the cells.  Masson trichrome stains collagen blue, nuclei black 
and cytoplasm red.  The trichrome stain also demonstrated similar collagen distribution 
from the cells (Figure 4.9 B-F).  Assembly and maturation of collagen plays a significant 
role in determining the biomechanics and the quality of the regenerated tissue.  Matrix 
metalloproteinases (MMPs) mediate delicate balance between different matrix elements 
by a variety of signaling mechanisms (Nelson et al. 2000, Park et al. 2004).  Gelatin 
turnover is mediated either by MMP-2 (Gelatinase A), a constitutively produced 
homeostatic enzyme, or by MMP-9 (gelatinase B) (Makowski et al. 1998), and 
upregulated in acute and chronic inflammations.  Previously, Pooja et al. have measured 
the activity of MMP-2/MMP-9 secreted into the growth medium of hFF-1 when cultured 
in FGM medium to understand whether the increased collagen secretion correlates to 
altered enzymatic degradation.  These results showed a significantly higher MMP-
2/MMP-9 activity in all gelatin containing hydrogels at day four than in tissue culture 
plastic.  Thus the increase in on an average, these structures showed two times more 
enzymatic activity than TCP.  This could be attributed to cells recognizing the denatured 
gelatin in these structures and trying to degrade them.   
Apart from collagen, cartilage also contains aggrecan proteoglycan, which contains 
chondroitin sulfate glycosaminoglycans.  In aggrecan, chondroitin sulfate is covalently 
bound to a core protein, which also has a binding domain for another long chain non-
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sulfated GAG hyaluronic acid.  These molecules form the complex aggrecan with 100 or 
more chondroitin sulfate chains bound to a core protein, and help in retaining large 
number of water molecules.  Shock absorption and friction reduction (lubricating action) 
are intrinsic functions of cartilage and may predominantly be attributable to a decrease in 
the amount of chondroitin sulfate chains contained by aggrecan.  Hence, presence of 
these molecules was analyzed by alcian blue stain.  The products from cellular secrection, 
acidic mucosubstances, hyaluronan, and sialomucins are stained in dark blue with the 
background materials being stained in red by Alcian blue with a pH of 2.5.  The collagen, 
cytoplasm and tissue are stained blue, light red, and dark red, respectively.  The negative 
control group did not have any production of GAGs into the matrix as seen in Figure 
4.10 B.  The results displayed similar distribution of matrix elements in the experimental   
and positive control groups in the 0.5% w/v hydrogel, but were in sparse quantities 
(Figure 4.10 B,C).  Whereas, the 2% hydrogel system contianed significantly more 
concentrated areas of GAGs in the matrix in both experimental and positve control 
groups (Figure 4.10 E,F).  However, further analysis is necessary to understand the 
content of these mucopolysaccharides.  
The increase of production in collagen and GAGs in the higher concentrated hydrogels 
can be attributed to the orientation of the cells with the hydrogels.  The 0.5% w/v gels 
contained encapsulated pellets and in the 2% w/v gels the cells were suspended.  Previous 
reports have shown that viability and proliferation of cells increase with the stiffness or 
strength of the scaffold (Discher et al. 2005, Yeung et al. 2005).  Furthermore, increasing 
cell differentation generallycorrelates with increasing substrate stiffness but varies from 
cell to cell (Wells 2008).  Also, suspension of the cells addresses the limitation of the  
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Figure 4.8. Haematoxylin and Eosin stain.  (A) hFF-1s in FBM on day 28.  (B) hMSCs in CCM on day 28.  (C) hFF-1s in CCM on 
day 28.  (D) hFF-1s in FBM on day 28.   (E) hMSCs in CCM on day 7.  (F) hFF-1s in CCM on day 7.   
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Figure 4.9. Masson’s Trichrome stain.  (A) hFF-1s in FBM on day 28.  (B) hMSCs in CCM on day 28.  (C) hFF-1s in CCM on day 
28.  (D) hFF-1s in FBM on day 28.   (E) hMSCs in CCM on day 7.  (F) hFF-1s in CCM on day 7.   
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Figure 4.10. Alcian Blue stain (pH 2.5).  (A) hFF-1s in FBM on day 28.  (B) hMSCs in CCM on day 28.  (C) hFF-1s in CCM on day 
28.  (D) hFF-1s in FBM on day 28.   (E) hMSCs in CCM on day 7.  (F) hFF-1s in CCM on day 7.  
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pellet of size inadequecy and poor processing ability.  However, the results for the 2% 
w/v hydrogels require longer culture periods and further analysis of the ECm components 
and cell viability and proliferation in the hydrogel. 
 
4.7 Matrix Metalloproteinase Activity 
MMPs degrade ECM components such as native and denatured collagens, elastin, 
laminin, and fibronectin (M.S. Agren et al. 1998).  Increased activity of these MMPs in 
cartilage and the synovial tissues has been found in patients suffering from osteoarthritis 
and rheumatoid arthritis (Nagase et al. 2003).  Gelatinases, or MMP-2 and MMP-9, are 
present for extended periods of time during the wound repair process (M.S. Agren 1994).  
Additionally, overexpressed collagenase levels have been linked to increased levels of 
MMP-9 during the involvement in collagen degradation (Iyer et al. 2011).  MMP-2 is 
expressed by MSCs but the activity is inhibited by tissue inhibitors of metalloproteases 
(Lozito et al, 2011).  Additionally, MMP-2 activity in fibroblasts is regulated by the 
mechanical strength of gels (Tomasek et al, 1997).  However, the main enzymes 
considered to be responsible for collagen and aggrecan degradation in cartilage are 
MMP-3, MMP-13, and MMP-14.  MMP-13 can cleave native fibrillar collagen types I, II, 
III, and V as well as several other ECM components, including type IV, X, and XIV 
collagens, large tenascin C, aggrecan, versican and fibronectin.  Furthermore, a role of 
MMP-13, which is produced by chondrocytes, is proposed in the excessive degradation 
of collagenous ECM in osteoarthritic cartilage (Kevorkian et al. 2004).  MMP-13 is 
expressed by fibroblasts in chronic cutaneous ulcers in vivo but not in normally healing 
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acute dermal wounds. (Ravanti, L et al., 1999).  MMP-13 mRNAs are expressed by 
human skin fibroblasts cultured in type I collagen gel but not by fibroblasts in monolayer 
cultures without TGF-β.  However, culturing fibroblasts in TGF-β containing medium 
induces MMP-13 expression. 
To understand the implication of incubating the hFF-1 and hMSCs in pellet form on 
hydrogels, activity of MMP-2/MMP-9 and MMP-13 were measured.  First, the activity of 
the MMP-2/MMP-9 and MMP-13 in the FBM and the CCM for all of the cultures was 
evaluated using respective fluorogenic substrates.  The relative fluorescence units (RFU) 
per microliter of the supernatant (RFU/μL) were measured for the media supernatants and 
fresh media.  There was a significant difference in the MMP-2/MMP-9 content in the 
fresh FBM and CCM media (Figure 4.11 C).  Relative to the fresh medium content, 
similar MMP-2/MMP-9 expressions were observed in all the negative and positive 
control samples, whereas the experimental group showed a reduced level (Figure 4.11 A, 
and Figure 4.11 A B).   
When MMP-13 activity was measured, there was no difference in the MMP-13 content in 
the fresh FBM and CCM media (Figure 4.12 C).  More MMP-13 expression was 
observed on day seven and day fourteen in the hMSC pellet cultures relative to the fresh 
media (Figure 4.12 A).  Similarly, days seven and twenty one of the experimental pellet 
group displayed an increased expression of MMP-13 content relative to the fresh media 
(Figure 4.12 A).  This increase in activity in the pellet cultures may be due to the cells 
creating intracellular space within the pellet causing degradation of the pellet thus 
expressing the MMP-13 enzyme.  In some cases of differentiation protocols, initial 
expression of MMP-13 in hMSCs and chondrocytes lead to hypertrophy and bone plate 
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formation (Bertramet al 2009).  Thus, the increased MMP-13 activity could also be due to 
the hypertrophic conditions.  Interestingly, minimal increases of MMP-13 were noticed in 
the positive and experimental groups cultured with the hydrogels (Figure 4.12 B).  This 
could be attributed to the differentiation of cells to chondrocytes.  Alternatively, 
decreased expressions of MMP-13 could be attributed to the cells attaching to the 
hydrogels and building the ECM rather than degrading the collagen from the hydrogels.   
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Figure 4.11. MMP-2/MMP-9 secreted into the medium throughout the 28 day culture period.  (A) Pellet system for hFF-1control 
group and hFF-1s and hMSCs in differentiation medium.  (B) Hydrogel system for hFF-1 control group and hFF-1s and hMSCs in 
differentiation medium. (C) Fresh medium used for cultures. 
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Figure 4.12. MMP-13 secreted into the medium throughout the 28 day culture period.  (A) Pellet system for hFF-1control group 
and hFF-1s and hMSCs in differentiation medium.  (B) Hydrogel system for hFF-1 control group and hFF-1s and hMSCs in 
differentiation medium. (C) Fresh medium used for cultures. 
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CHAPTER V 
 
 
CONCLUSIONS AND RECOMMENDATIONS 
5.1 Conclusions 
There were two objectives for this study: 
1. The first objective was to evaluate a hydrogel system that is easy to utilize in the 
clinical settings to produce cartilage.  From the thermal gelation studies, the gelation of 
chitosan occurs with the addition of gelatin and gelation temperature decreases with the 
increase in chitosan concentration.  From the elastic moduli experiments, increasing 
chitosan and gelatin concentration showed improved elastic modulus.  
2. The second objective was to investigate an autologous cell source such as hFF-1s as a 
source for chondrocytes and measure viability in a regenerative tissue.  From the 
viability, differentiation, and proliferation studies, the hFF-1s were observed to follow 
similar trends to the positive control hMSCs after twenty eight days of culture in 
complete chondrogenic medium.  This was supported by the cell morphology and 
collagen distribution studies where the cells and collagen in the ECM produced by each 
cell line could be observed as embedding in the chitosan-gelatin tissue.  Additionally, the 
cells were noticed to have a round shape which is concurrent with chondrocytes. 
However, in the initial tissue culture plastic cultures the hFF-1s were examined to be 
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reduced in size but similar in shape to the hMSCs.  Collagen Type II ELISA was 
performed to evaluate the collagen leaching of the cells into the media supernatant.  Both 
the control and experimental forms of the fibroblasts followed the same progression as 
the stem cells for in the pellet cultures.  The hydrogel cultures showed a significant 
increase initially in all groups.  After the initial jump, the collagen secretion decreased 
and followed an increasing pattern throughout the rest of the culture period in all groups.  
Flow cytometry analysis was done on experimental hFF-1 0.5% and 2%/1% w/v 
hydrogel and hMSC pellet cultures with the detection of antibody surface markers CD44 
PE and CD151 FITC. The 0.5% w/v hydrogel culture followed the same trends for both 
antibodies as the unstained control group.  The 2%/1% w/v hydrogel culture displayed an 
up-regulation in both antibodies.  The hMSC pellet culture followed the trend of the 
CD151 FITC antibody but exhibited an up-regulation in the CD44 PE antibody.  
Increases in extracellular matrix accumulation were observed in hFF-1 and hMSC 
cultures containing hydrogel and chondrogenic induction medium.  Positive and negative 
control groups displayed similar results of MMP-2/MMP-9 expression in all samples 
with a reduction in expression in the experimental group relative to the media.  
Experimental and positive control pellet cultures showed higher expressions of MMP-13 
early in the culture relative to CCM.   Hydrogel cultures had minimal increases in all 
cultures relative to media. 
Overall Summary:  In summary, a hydrogel system that displays mechanical properties 
(12-15 kPa) that is more closely useable for clinical settings has been observed, an 
autologous cell source such as hFF-1s have suggested the possibility of differentiation 
into chondrocytes as well as viability and proliferation in the explored hydrogel systems.  
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5.2 Recommendations 
1. This study is exploration into the possibility of differentiation of an autologous cell 
source into a low regenerative cell line and the relationship between the physical and 
chemical characteristics of the biomaterial structures with respect to the biological 
responses of the cell lines.  Although the mechanical characteristics of the regenerative 
tissue have been observed, evaluation of the complete makeup of the structure has yet to 
be experimented.  In the future, this can be done by preparing hydrogel systems with the 
inclusion of hyaluronan, which is another ECM component naturally found in cartilage. 
This would complete the necessary components in the hydrogel to most closely represent 
cartilage in its natural state.   
2. The size and shape factor analysis is a useful tool for comparing the size and shape of 
different cell lines.  In the case of this study the two cells lines explored are spindle 
shaped and range in size. The chondrocyte shape on the other hand is round or circular 
shaped and of a medium size in cells.  For this study the initial size and shape analysis 
was done of each cell line prior to undergoing differentiation.  While cells are being 
differentiated, the cell size and shape are drastically altered to be consistent with the cell 
line that is desired. Further analysis needs to be done at the end of the differentiation 
culturing period to determine the transformation of the cell into the chondrocyte cell line.  
This will be an inclusion to the histochemistry that has been done to complete the 
analysis of differentiation by physical aspects.  
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3. The physical structure of cartilage is made up of many extra cellular matrix 
components, which include Collagen Type II, Aggrecan, Matrix Metalloproteinases 
(MMPs), and Tropoelastin.  Aggrecan is a naturally occurring proteoglycan and 
Tropoelastin is the base molecule for forming elastin.  Both are proteins naturally found 
in the ECM of articular cartilage.  The MMPs associated with cartilage are known as 
Aggrecanases and are secreted by chondrocytes. There are multiple MMPs found in 
cartilage and each of them degrades the extracellular matrix proteins such as collagen, 
Aggrecan, and elastin.  In this study Collagen Type II was explored and evaluated in the 
supernatant of the culture systems.  In the future, Collagen Type II, Aggrecan, Matrix 
Metalloproteinases (MMPs), and Tropoelastin content should be measured in the 
regenerated tissue. This must be to done to make the hydrogel mimic the structural 
integrity as well as make up of articular cartilage.  
4. Flow cytometry is used for multiple purposes.  In this research, it was used for the 
detection of surface markers CD44 and CD151.  Future analysis should include the 
measurement of more antibodies such as CD168 and CD49a. CD168 is a hyaluronan-
mediated motility receptor that binds to hyluronan and alters migratory cell behavior.  
CD49a is an integrin alpha sub unit involved in cell adhesion and is a receptor for 
laminin.  Each of these antibodies plays an important role in chondrogenesis and is 
necessary for completion of the work for promotion of clinical studies.  
5. Histology is a used for qualitative analysis of in the interaction of cells with the tissue.  
Haematoxylin and Eosin (H&E) and Masson’s Trichrome were used in this study to 
determine cell morphology and collagen distribution, respectively. For future studies, 
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Alcian Blue stain at a pH of 1.0 should be explored.  This stain is specific for 
chondrocytes and cartilage extra cellular matrix components.   
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